AI assistant
Sending…
Sanofi — Capital/Financing Update 2011
May 3, 2011
1643_rns_2011-05-03_8894d687-2fa9-4a2f-844a-2c638aaa4a41.pdf
Capital/Financing Update
Open in viewerOpens in your device viewer
Paris, May 2, 2011
AMENDMENT TO THE LIQUIDITY CONTRACT WITH EXANE BNP PARIBAS
Sanofi-aventis announced on May 2, 2011 the signature of an amendment to the liquidity contract signed with EXANE BNP PARIBAS on September 16, 2010.
This amendment modifies the resources allocated to the contract which now consist of:
- 10,000,000 Euros (instead of 40,000,000 Euros initially of which 20,000,000 euros had been made available);
- Zero Sanofi-aventis shares.
Investor Relations Department Europe Tel: + 33 1 53 77 45 45 US Tel: + 1 908 981 5560 e-mail: [email protected]
Media Relations Department Tel: + 33 1 53 77 44 50 e-mail: [email protected]
More from Sanofi
Regulatory Filings
2026
May 19
Regulatory Filings
2026
May 19
Regulatory Filings
2026
May 18
Regulatory Filings
2026
May 18
Regulatory Filings
2026
May 5
Transaction in Own Shares
2026
Apr 29
Transaction in Own Shares
2026
Apr 29
Declaration of Voting Results & Voting Rights Announcements
2026
Apr 29
Declaration of Voting Results & Voting Rights Announcements
2026
Apr 29
Regulatory Filings
2026
Apr 29